Navigation Links
New medication shows promise as lipid-lowering therapy for rare cholesterol disorder
Date:11/2/2012

se was 40 mg per day. At the end of the efficacy phase, LDL-C levels were reduced by an average of 50 percent from baseline. Approximately one-third of the patients experienced levels of LDL-C that were less than 100 mg/dl close to the recommended therapeutic goals at some point during the study, and concomitant lipid-lowering therapy was modified in a subset of these patients during the safety phase. Despite these changes in treatment, patients' mean LDL-C levels were still reduced by 38 percent at the end of the study.

"The magnitude of this reduction in LDL-C and the fact that some patients reached or approached the LDL-C therapeutic goals is truly remarkable for this high risk population that historically doesn't respond to lipid-lowering drugs," said the study's lead author, Marina Cuchel, MD, PhD, research assistant professor of Medicine at Penn. "A reduction in LDL-C of this magnitude is certainly expected to favorably alter the clinical course of this devastating disease."

Senior study author Daniel J. Rader, MD, chief, Division of Translational Medicine and Human Genetics at Penn, has treated HoFH patients for more than two decades. In the early 1990s, Rader worked with colleagues to determine that mutations in MTP were the cause of a rare condition characterized by absent LDL in the blood, establishing MTP as a therapeutic target to reduce LDL. His colleagues then went on to discover the MTP inhibitor lomitapide at Bristol-Myers Squibb (BMS). Rader led a study at Penn in the late 1990s showing that lomitapide substantially reduced LDL in patients with moderately elevated LDL. However, because the agent caused some gastrointestinal side effects and increased liver fat, BMS decided to abandon further development of lomitapide for a much larger population of patients with elevated levels of cholesterol. Rader convinced BMS to donate the drug to Penn so that he could continue to develop it in patients with HoFH. Based on its mechanism a
'/>"/>

Contact: Jessica Mikulski
jessica.mikulski@uphs.upenn.edu
215-349-8369
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Forgoing Medication, for Babys Sake
2. Parents poor math skills may lead to medication errors
3. Reducing off-label use of antipsychotic medications may save money
4. Common acne medication doubles risk of eye infection
5. Misuse of over-the-counter pain medication is potential health threat
6. Genes predict if medication can help you quit smoking
7. Acne Medication May Raise Risk of Eye Infections
8. New delivery method improves efficacy of 2 common Parkinsons disease medications
9. Mount Sinai researcher finds timing of ADHD medication affect academic progress
10. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
11. Physicians dont adequately monitor patients medication adherence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Aspen, CO (PRWEB) , ... July 07, 2015 ... ... 726 skin cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible ... These potential diagnoses must be confirmed with additional testing. , The Aspen Ideas ...
(Date:7/7/2015)... ... July 07, 2015 , ... A June 29th ... that have emerged about Hillary Clinton. Two plastic surgeons consulted by the publication ... than she has in some time and speculate that she might have benefited ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, ... VE and CelestixFederated VA Series virtual appliances. These virtual platforms expand the ... products, which have proven to simplify the on-premises deployment of unified remote access ...
(Date:7/7/2015)... N.J. (PRWEB) , ... July ... ... CTLT), the leading global provider of advanced delivery technologies and development solutions ... signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... enhance the experience for its patient community using its IDF ePHR, an electronic ... with primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... a specific marker in the blood and tissues of certain ... they can be infected// for years with SIV, the primate ... published by Tulane University pathologist Ivona Pandrea in the scientific ... and intestines of five primate species that do not develop ...
... Rajasthan need not despair about becoming doctors. Rajasthan Medical University// ... move that is being questioned by many. ... number of failures in MBBS and to help those students ... ,As many as 25 students from Jaipur's SMS ...
... have doomsday predictions for the country’s health scenario unless drastic ... According to statistics released by the health ministry of Malaysia, ... HIV infected person by 2015. ,Of a population ... virus. , The figures show an increase of ...
... pregnant women are to be monitored more carefully according ... Francisco, as they are at a higher risk of giving ... , Mert Ozan Bahtiyar of Yale School of Medicine, who ... subjects, led the study. ,It was seen that ...
... According to a latest study sleep deprivation could affect the ... group of researchers// from Princeton University. They conducted this study ... rats – one group whose sleep was deprived for 72 ... indicated that lack of sleep in the first group affected ...
... case at United World College in the northeastern New Mexico ... the disease. ,Officials at the college near Las ... hospitalized with an infectious form of the disease. ... the lungs and other parts of the body. It is ...
Cached Medicine News:Health News:Tuberculosis Case Alarms Health Officials 2
(Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
(Date:7/7/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ... protection systems ("EPS"), today announced that its MGuard ... MicroNet ™ has received the Frost & ... Award.  Through active market research efforts, Frost & ... the successful introduction of new and innovative products, ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, ... within human and veterinary oncology, today announced that ... the United States , designed to ... animal therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... , Paccal Vet-CA1 was previously distributed ...
Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... April 29, 2011 Centocor Ortho Biotech Products, L.P., ... Drug Application (NDA) for trabectedin for the treatment of ... based on the U.S. Food and Drug Administration,s (FDA) ... to obtain approval. The NDA was submitted ...
... Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy ... of the Year. The award was announced at ... annual award along with Grant Thornton LLP, WWJ Newsradio 950 ... Hagerman was chosen from among 45 nominees profiled during the ...
Cached Medicine Technology:Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 3